Financhill
Back

Neumora Therapeutics Quote, Financials, Valuation and Earnings

Neumora Therapeutics Price Quote

$10.33
+0.01 (+-2.36%)
(Updated: December 14, 2024 at 5:44 AM ET)

Neumora Therapeutics Key Stats

Sell
26
Neumora Therapeutics (NMRA) is a Sell

Day range:
$10.08 - $10.80
52-week range:
$8.33 - $21.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.33%

Volume:
859.2K
Avg. volume:
1M
1-year change:
-27.58%
Market cap:
$1.7B
Revenue:
$0
EPS:
$-1.84

How Much Does Neumora Therapeutics Make?

Data Unavailable

Is Neumora Therapeutics Growing As A Company?

Data Unavailable

Neumora Therapeutics Stock Price Performance

What Is Neumora Therapeutics 52-Week High & Low?

Neumora Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Neumora Therapeutics?

Is Neumora Therapeutics Cash Flow Positive?

  • What Is NMRA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$184M
  • What Is Neumora Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $5.5M
  • What Is Neumora Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $41.9M

Neumora Therapeutics Return On Invested Capital

Data Unavailable

Neumora Therapeutics Earnings Date & Stock Price

Neumora Therapeutics Competitors

Neumora Therapeutics Dividend Yield

Neumora Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -18.33%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 23.33
Upside from Last Price: 126.02%

Major Shareholders

  • How many NMRA shares are owned by institutional investors?
    85.4M NMRA shares are owned by institutional investors
  • How many NMRA shares are owned by insiders?
    9.3M NMRA shares are owned by insiders